Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.7K
Overview
64.7K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS.

Bone marrow transplantation·2026
Same author

T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL.

Blood neoplasia·2025
Same author

Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.

The New England journal of medicine·2025
Same author

Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS.

NEJM evidence·2025
Same author

Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.

Frontiers in immunology·2025
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Allogeneic transplantation as anticancer immunotherapy.

Simrit Parmar1, David S Ritchie2

  • 1MD Anderson Cancer Centre, Houston, TX, USA.

Current Opinion in Immunology
|February 19, 2014
PubMed
Summary
This summary is machine-generated.

Allogeneic stem cell transplantation (AlloSCT) leverages donor immune cells to fight cancer via the graft-versus-tumor (GVT) effect. Reduced-intensity AlloSCT regimens harness GVT while minimizing treatment toxicity.

More Related Videos

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

17.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Related Experiment Videos

Last Updated: May 3, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

17.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Allogeneic stem cell transplantation (AlloSCT) restores blood cell production and immunity.
  • The graft-versus-tumor (GVT) effect, mediated by donor lymphocytes, is crucial for anti-cancer activity in AlloSCT.
  • Reduced-intensity conditioning regimens have been developed to decrease AlloSCT-related morbidity and mortality.

Purpose of the Study:

  • To explore the mechanisms of the GVT effect in AlloSCT.
  • To understand how GVT contributes to long-term cancer control.
  • To investigate the potential for non-allogeneic immunotherapies based on AlloSCT insights.

Main Methods:

  • Clinical observations of AlloSCT patients.
  • Experimental models of AlloSCT.
  • Analysis of donor lymphocyte populations and their anti-cancer activity.

Main Results:

  • AlloSCT's anti-cancer efficacy is significantly attributed to the GVT effect.
  • Reduced-intensity regimens maintain GVT while lowering treatment complications.
  • Insights from AlloSCT provide a basis for developing novel immunotherapies.

Conclusions:

  • The GVT effect is a key mechanism for malignancy control post-AlloSCT.
  • Optimized AlloSCT protocols enhance therapeutic benefits by balancing GVT and reduced toxicity.
  • Understanding AlloSCT-induced immunity offers new avenues for cancer immunotherapy development.